天麻颈脑宁治疗视疲劳的临床观察

Clinical Observation on TianMa JingNaoNing in the Treatment for Asthenopia

目的：观察天麻颈脑宁片治疗视疲劳的临床疗效。方法：将视疲劳患者60例随机分为天麻组30例，服用天麻颈脑宁片5片，3次/d；对照组30例玻璃酸钠滴眼液滴眼，4～6次/d，治疗1个月后观察2组患者各项症状、体征积分及临床疗效。结果：天麻组患者临床症状改善明显，总有效率达96.67%，对照组总有效率93.33%，2组临床疗效比较差异有统计学意义（P＜0.01），其中身体症状积分改善天麻组优于对照组（P＜0.01）；眼部症状积分改善2组比较差异无统计学意义（P＞0.05）；角膜上皮脱落积分比较对照组优于天麻组（P＜0.01）；球结膜充血积分2组比较差异无统计学意义（P＞0.05）。结论：天麻颈脑宁片能明显改善视疲劳症状、体征，对全身症状、体征改善尤为明显。

Objective：To observe clinical efficacy of TianMa JingNaoNing tablets in treating asthenopia. Methods：Sixty patients were randomized into TianMa group, who took TianMa JingNaoNing tablets, five pills, three times per day;the control group received sodium hyaluronate eye drops, four to six times per day, to observe the integrals of the symptoms and body signs as well as clinical effects after treating for one month. Results：Clinical symptoms of TianMa group were improved obviously, total effective rate of the disease reached 96.67%, higher than 93.33%of the control group, the difference between both groups was significant in clinical effects （P〈0.01）, among them, TianMa group was superior to the control group in the integrals of body symptoms （P〈0.01）;the difference had no statistical meaning in the improvement of eye symptom integrals（P〉0.05）;the control group was better than TianMa group in the integrals of corneal epithelium exfoliation （P〉0.01）; the difference showed no statistical meaning between both groups in the integrals of bulbar conjunctiva congestion （P〈0.05）. Conclusion：TianMa JingNaoNing tablets could improve the symptoms and body signs of asthenopia obviously, especially the symptoms and body signs.